In the BioHarmony Drug Report Database

"Preview" Icon

Tepotinib

Tepmetko (tepotinib) is a small molecule pharmaceutical. Tepotinib was first approved as Tepmetko on 2021-02-03. The pharmaceutical is active against hepatocyte growth factor receptor. Tepmetko’s patents are valid until 2030-03-19 (FDA).

 

Trade Name

 

Tepmetko
 

Common Name

 

tepotinib
 

ChEMBL ID

 

CHEMBL3402762
 

Indication

 

 

Drug Class

 

Tyrosine kinase inhibitors

Image (chem structure or protein)

Tepotinib structure rendering